Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

30 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Efficacy of a Drug-Eluting Stent Versus Bare Metal Stents for Symptomatic Femoropopliteal Peripheral Artery Disease: Primary Results of the EMINENT Randomized Trial.
Gouëffic Y, Torsello G, Zeller T, Esposito G, Vermassen F, Hausegger KA, Tepe G, Thieme M, Gschwandtner M, Kahlberg A, Schindewolf M, Sapoval M, Diaz-Cartelle J, Stavroulakis K; EMINENT Investigators. Gouëffic Y, et al. Circulation. 2022 Nov 22;146(21):1564-1576. doi: 10.1161/CIRCULATIONAHA.122.059606. Epub 2022 Oct 18. Circulation. 2022. PMID: 36254728 Free article. Clinical Trial.
Paclitaxel-Coated Balloons for the Treatment of Symptomatic Central Venous Stenosis in Vascular Access: Results From a European, Multicenter, Single-Arm Retrospective Analysis.
Kitrou PM, Steinke T, El Hage R, Ponce P, Lucatelli P, Katsanos K, Spiliopoulos S, Spinelli A, Bisdas T, Stavroulakis K, Jaffer O, Mallios A, Zilahi de Gyurgyokai S, Cancellieri R, Coscas R, Karnabatidis D. Kitrou PM, et al. Among authors: jaffer o. J Endovasc Ther. 2021 Jun;28(3):442-451. doi: 10.1177/15266028211007471. Epub 2021 Apr 9. J Endovasc Ther. 2021. PMID: 33834905
A multicenter randomized controlled trial indicates that paclitaxel-coated balloons provide no benefit for arteriovenous fistulas.
Karunanithy N, Robinson EJ, Ahmad F, Burton JO, Calder F, Coles S, Das N, Dorling A, Forman C, Jaffer O, Lawman S, Lakshminarayan R, Lewlellyn R, Peacock JL, Ramnarine R, Mesa IR, Shaikh S, Simpson J, Steiner K, Suckling R, Szabo L, Turner D, Wadoodi A, Wang Y, Weir G, Wilkins CJ, Gardner LM, Robson MG. Karunanithy N, et al. Among authors: jaffer o. Kidney Int. 2021 Aug;100(2):447-456. doi: 10.1016/j.kint.2021.02.040. Epub 2021 Mar 27. Kidney Int. 2021. PMID: 33781793 Free article. Clinical Trial.
Von Willebrand factor.
Bhogal P, Jensen M, Hart D, Makalanda L, Collins GB, Spooner O, Jaffer O. Bhogal P, et al. Among authors: jaffer o. Clin Med (Lond). 2020 Nov;20(6):e279. doi: 10.7861/clinmed.Let.20.6.3. Clin Med (Lond). 2020. PMID: 33199342 Free PMC article. No abstract available.
Vascularity of Intra-testicular Lesions: Inter-observer Variation in the Assessment of Non-neoplastic Versus Neoplastic Abnormalities After Vascular Enhancement With Contrast-Enhanced Ultrasound.
Lung PFC, Fang C, Jaffer OS, Deganello A, Shah A, Hedayati V, Obaro A, Yusuf GT, Huang DY, Sellars ME, Quinlan DJ, Sidhu PS. Lung PFC, et al. Among authors: jaffer os. Ultrasound Med Biol. 2020 Nov;46(11):2956-2964. doi: 10.1016/j.ultrasmedbio.2020.07.028. Epub 2020 Aug 27. Ultrasound Med Biol. 2020. PMID: 32863063
30 results